QRxPharma

NCT01280331

Phase 3, Completed, 2011, 375 people, 20 Jan 2011, clinicaltrials.gov

NCT01055015

Phase 3, Completed, 2010, 141 people, 25 Jan 2010, clinicaltrials.gov

NCT01016808

Phase 3, Completed, 2009, 522 people, 20 Nov 2009, clinicaltrials.gov

NCT00831051

Phase 2, Completed, 2008, 197 people, 28 Jan 2009, clinicaltrials.gov

NCT00818493

Phase 2, Completed, 2009, 44 people, 7 Jan 2009, clinicaltrials.gov

NCT00560183

Phase 3, Completed, 2007, 256 people, 19 Nov 2007, clinicaltrials.gov